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Background: Influenza A virus non-structural protein 1 (NS1) is a virulence factor, which is targeted into the cell
cytoplasm, nucleus and nucleolus. NS1 is a multi-functional protein that inhibits host cell pre-mRNA processing
and counteracts host cell antiviral responses. Previously, we have shown that the NS1 protein of the H3N2 subtype
influenza viruses possesses a C-terminal nuclear localization signal (NLS) that also functions as a nucleolar
localization signal (NoLS) and targets the protein into the nucleolus.
Results: Here, we show that the NS1 protein of the human H3N2 virus subtype interacts in vitro primarily via its
C-terminal NLS2/NoLS and to a minor extent via its N-terminal NLS1 with the nucleolar proteins, nucleolin and
fibrillarin. Using chimeric green fluorescence protein (GFP)-NS1 fusion constructs, we show that the nucleolar
retention of the NS1 protein is determined by its C-terminal NLS2/NoLS in vivo. Confocal laser microscopy analysis
shows that the NS1 protein colocalizes with nucleolin in nucleoplasm and nucleolus and with B23 and fibrillarin in
the nucleolus of influenza A/Udorn/72 virus-infected A549 cells. Since some viral proteins contain NoLSs, it is likely
that viruses have evolved specific nucleolar functions.
Conclusion: NS1 protein of the human H3N2 virus interacts primarily via the C-terminal NLS2/NoLS and to a minor
extent via the N-terminal NLS1 with the main nucleolar proteins, nucleolin, B23 and fibrillarin.
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Influenza A virus genome consists of eight separate
RNA segments, which encode for 12 viral structural and
nonstructural proteins [1]. In addition to the viral
hemagglutinin (HA), nonstructural protein 1 (NS1) is
one of the major viral virulence factors. The evolution of
NS genes appears to be species-specific, and the evolu-
tion of present seasonal human NS genes began in 1918,
when H1N1 type viruses emerged and became pandemic
[2]. With the most recent pandemic in 2009 caused by
the swine-origin influenza A virus, the NS gene was* Correspondence: krister.melen@thl.fi
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reproduction in any medium, provided the orchanged, and it was originating from classical swine
influenza viruses [3].
Influenza A virus NS1 is a multi-functional protein
that contains an N-terminal dsRNA-binding domain and
a C-terminal effector domain. Experiments with the
human H3N2 influenza A/Udorn/72 virus demonstrated
that the primary role of the NS1 dsRNA-binding activity
is to inhibit the activation of IFN-induced 2’-5’ oligo (A)
synthetase/RNase L pathway [4]. Instead, experiments
with the mouse-adapted H1N1 influenza A/PR8/34 virus
indicated that the RNA-binding domain participates in
the NS1 protein-mediated inhibition of the activation
of the retinoic acid-inducible gene I (RIG-I) [5,6] which
is required for the influenza A virus-induced cytokine
gene expression [7-9]. The effector domain of NS1
binds to two cellular proteins that are essential for the 3’td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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result, the processing of cellular pre-mRNAs, including
interferon-β (IFN-β), is inhibited [12-15]. In addition,
the NS1 protein of influenza A virus has been shown to
interact with protein kinase R (PKR), PACT, Crk/CrkL,
TRIM25 and the p85 component of the PI-3 kinase
pathway [16-21].
Eukaryotes have a nucleolus, which is a relatively large,
dynamic and highly organized non-membranous sub-
compartment of the nucleus. The nucleolus is the site
for ribosomal RNA synthesis, processing and maturation
[22,23]. Recently, it has become apparent that nucleolus
also has a role in regulating the cell cycle, tumor sup-
pression and oncogenic activities, the assembly of signal
recognition particle (SRP), the control of aging and the
modulation of telomerase functions [24-26]. Some of
these functions are mediated through the sequestration
of transcription factors that control the cell cycle
[26,27]. Recent studies show that the nucleolus is made
up of numerous protein-protein and protein-nucleic acid
interactions that are constantly changing in response
to the metabolic conditions of the cell [28]. Nucleolus
is divided into three discrete regions: fibrillar centres,
surrounded by dense fibrillar component (DFC), which
in turn is surrounded by a granular component (GC)
(reviewed in [23,29]).
Three distinct subsets of nucleolar proteins have been
identified. Primarily, fibrillarin is a small nucleolar ribo-
nucleoprotein (snoRNP), which is associated with early
pre-rRNA transcripts during elongation and is localizing
to DFC. B23/NPM protein is a putative ribosome assem-
bly factor involved in 28S rRNA processing and ribo-
some assembly that localized in the GC, while the third
major nucleolar protein, nucleolin, is involved in the
processing of precursor rRNAs [30].
Nucleolar localization signals (NoLSs) that regulate
nucleolar localization and retention are usually rich in
arginine and lysine residues, which overlap with NLSs.
However, there is no obvious consensus NoLS sequence
or structure [31-33]. Nuclear proteins pass through the
nucleolus randomly, and those, with affinity to constitu-
tive nucleolar components, are retained. It has been sug-
gested that NoLSs act as retention signals rather than as
classical targeting or transport signals [27,34]. It was
possible to target the green fluorescent protein (GFP)
into the GC of the nucleoli using sequences interacting
with the acidic domains of B23/NPM [35].
Within the last few years, increasing evidence has
revealed that viruses require the nucleus and in particu-
lar the nucleolus for their replication [36]. In addition to
N-terminal NLS1, the C-terminus of the NS1 proteins of
H3N2 and H2N2 influenza viruses have another NLS,
NLS2, which also functions as a NoLS and targets theprotein into the nucleolus [37]. A functional NLS2/NoLS
of the Udorn H3N2 virus NS1 protein required basic
arginine/lysine residues at its C-terminal end for nucle-
olar localization to take place [37]. Seasonal H1N1 virus
NS1 proteins seem to lack these C-terminal basic resi-
dues. In addition, the C-terminal end of the H5N1 (avian
virus) and H1N1pdm09 NS1 protein resembles those of
the seasonal H1N1 subtype viruses or have a 15 amino
acid truncation, respectively, and are thus likely to lack
the C-terminal NLS2/NoLS. Murayama and co-workers
identified nucleolin, an abundant nucleolar protein as
a novel NS1-binding protein [38]. By laser confocal
microscopy, they observed the co-localization of NS1
with nucleolin most clearly in the nucleoli, suggesting
that NS1 was interacting with nucleolin during the infec-
tion [38].
Here, we show that the NS1 protein of the human
H3N2 virus interacts primarily via the C-terminal NLS2/
NoLS and to a minor extent via the N-terminal NLS1
with the main nucleolar proteins, nucleolin, B23 and
fibrillarin. Direct interactions were observed for nucleo-
lin and fibrillarin but not with in vitro-translated B23.
Using GFP-NS1 fusion proteins, we show that the
nucleolar retention of the NS1 protein is determined by
its C-terminal NLS2/NoLS in vivo. Confocal laser mi-
croscopy results show that the NS1 protein colocalizes
with nucleolin in nucleolus and nucleoplasm and with
B23 and fibrillarin in nucleolus in influenza A/Udorn/72
virus-infected A549 cells.
Results
NS1 proteins, containing a C-terminal NLS2/NoLS, are
targeted into the nucleoli in H3N2 subtype influenza A
virus-infected A549 cells
We have previously shown that the NS1 protein of the
H3N2 subtype influenza A viruses contain a C-terminal
NLS2/NoLS (Figure 1A) that targets the protein into the
nucleoli in virus-infected cells [37]. To further confirm
this observation, we infected A549 cells with wild type
recombinant H1N1 subtype A/WSN/33 and A/WSN/33
virus expressing the 1918 NS gene (A/Brevig Mission/1/
18 segm 8), H3N2 subtype A/Udorn/72, H1N1pdm09
subtype A/Fin/554/09 and avian H7N3 subtype A/mal-
lard/Netherlands/12/00 viruses for nine h. After fixation
of the cells, NS1 protein expression was detected using
anti-NS1 protein-specific antibodies (Figure 1C). In gen-
eral, all analyzed NS1 proteins were mainly observed to
be localized in the cell nuclei. As an exception, the NS1
protein of the A/Udorn/72 virus was observed in the
cell nucleus and enriched in nucleoli while a weaker
nucleolar staining was seen in A/WSN/33 virus-infected
cells (Figure 1C). The NS1 proteins of the recombinant
A/WSN/33 (A/Brevig Mission/1/18 segm 8), A/mallard/
Figure 1 NS1 protein in H3N2 type influenza A viruses targets into the nucleolus in virus-infected A549 cells. (A) A schematic
representation of the intracellular targeting signals of the A/Udorn/72 virus NS1 protein. (B) Variations of putative C-terminal NLS2/NoLSs in
selected influenza A virus NS1 proteins are presented. Critical amino acids 219, 220, 224, 227, 229, 231, and 232 that are involved in targeting the
NS1 protein into the nucleus and nucleolus [37] are shown in boldface. (C) A549 cells grown directly on coverslips were infected with
recombinant influenza A/WSN/33 (A/Brevig Mission/1/18 segm 8) or wt A/WSN/33 (H1N1), A/Udorn/72 (H3N2), A/Fin/554/09 (H1N1pdm09) and
A/Mallard/Netherlands/12/00 (H7N3) viruses (MOI 5) for 9 h as indicated in the figure. After fixation, the cells were stained with rabbit anti-NS1
and fluorescein isothiocyanate-labeled anti-rabbit immunoglobulins, followed by analysis with confocal laser microscopy. Bar, 5 μm.
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were mainly excluded from nucleoli, even though clear
nucleolar staining was still detected in few cells.
NS1 protein can change its location over the time
course of infection. NS1 is nuclear in the beginning andboth nuclear and cytoplasmic at later stages of the infec-
tion [37]. Cytoplasmic translocation is mediated by a
nuclear export signal (NES) [39]. Cellular localization
emphasizes the specific functions of the NS1 protein in
the cytoplasm, nucleus and nucleolus.
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C-terminus of the H3N2 subtype influenza A/Udorn/72
virus is targeted into the nucleoli in transiently
transfected HuH7 cells
Next, fragments of the NS1 genes encoding for amino
acids 1–73 and 157–237 of the NS1 protein of A/
Udorn/72 virus, for amino acids 1–73 and 157–230 of
the NS1 protein of A/WSN/33 virus and for amino acids
203–230 of the NS1 protein of A/Brevig Mission/1/18
virus were inserted into a GFP expression vector pCMX-
SAH/Y145F and GFP-NS1 fragment fusion proteins
were transiently expressed in HuH7 cells (Figure 2). The
N-termini (amino acids 1–73) of the H3N2 and H1N1
subtype influenza virus NS1 proteins, containing the
NLS1 (Figure 2A), efficiently targeted the fusion proteins
into the cell nucleus but not to the nucleoli which
appeared to remain negative (Figure 2B and C). The C-
terminal part (amino acids 157–237) of the NS1 protein
of the H3N2 subtype influenza virus, containing the
NLS2/NoLS, also targeted the fusion protein into the
cell nucleus but, in addition, concentrated strongly in
the nucleoli (Figure 2B). The mutation of several basic
arginine (R) and lysine (K) residues to alanine (A) of the
NLS2/NoLS (K219A,R220A+R231A,R232A) abolished
the accumulation of this fusion protein into the host
cell nucleus and nucleoli and led to a localization of the
fusion protein similar to that of GFP (Figure 2B). Simi-
larly, the GFP-NS1 A/WSN/33 (amino acids 157–230)
and GFP-NS1 A/Brevig Mission/1/18 (amino acids 203–
230) fusion proteins did not clearly accumulate nei-
ther in the nucleus nor in nucleoli and exhibited a
localization rather comparable to that of the GFP alone
(Figure 2C).
The C-terminal NoLS of the influenza A/Udorn/72
NS1 protein binds to nucleolar proteins nucleolin,
B23 and fibrillarin
Next, we carried out pull-down experiments using A549
cell extracts to identify the nucleolar proteins that could
interact with influenza A virus NS1 protein. In these
experiments wt NS1 protein of the H3N2 subtype A/
Udorn/72 influenza virus was observed to interact with
nucleolin, B23 and fibrillarin (Figure 3B). The 1918
H1N1 subtype A/Brevig Mission/1/18 virus NS1 protein
was observed to interact with nucleolin and B23 and the
H7N3 subtype A/mallard/Neatherlands/12/00 virus NS1
protein with B23 and fibrillarin but these interactions
were weak (Figure 3B). Unfortunately, the expression
levels of GST-NS1 A/Brevig Mission/1/18 and GST-NS1
A/mallard/Neatherlands/12/00 fusion proteins were
much lower than that of GST-NS1 A/Udorn/72. Thus,
the relative binding intensities of these proteins with
nucleolar proteins could not be compared (Figure 3B).
Previously, it has been suggested that the N-terminalRNA-binding domain of the NS1 binds nucleolin [38].
To further confirm this observation in our experimental
system, we used GST-NS1 A/Udorn/72 (amino acids 1–
73) fusion protein (Figure 3A) in pull-down experiments
and found a weak binding of nucleolin, B23 and fibril-
larin to the N-terminal part of NS1. The binding was
totally abolished by R38A and K41A substitution muta-
tions to the RNA-binding domain, which are the critical
amino acids that form the NLS1 of the NS1 protein
(Figure 3B). Conversely, the GST-NS1 A/Udorn/72
(amino acids 203–237) fusion protein pulled-down the
nucleolar proteins, nucleolin, B23 and fibrillarin at least
as well as the wt NS1 protein did (Figure 3B) showing
the predominant role of the C-terminus of the NS1
protein in the interactions of NS1 with nucleolin, B23
and fibrillarin. These bindings were totally abolished
by K219A,R220A+R231A,R232A substitution mutations
(Figure 3B) highlighting the importance of NLS2/NoLS
sequences in the interaction with nucleolar proteins.
The C-terminal NLS2/NoLS of the NS1 protein of the
influenza A/Udorn/72 virus bound in vitro-translated
nucleolin and fibrillarin but not in vitro-translated B23
in a GST pull-down experiment
Next, to verify our previous binding results and to know
whether the interactions between NS1 protein and
nucleolar proteins occur directly or indirectly via other
proteins, we carried out pull-down experiments using
in vitro-translated [35S]-methionine-labeled nucleolin,
B23 and fibrillarin. The procedure is described in the le-
gend of Figure 4 and the GST-NS1 fusions were the
same as in the experiments described above (Figure 3).
The wt NS1 protein of the H3N2 subtype A/Udorn/72
influenza virus bound directly the in vitro-translated
nucleolin and fibrillarin but not the in vitro-translated
B23 (Figure 4). Instead, the wt NS1 protein of the H1N1
subtype A/Brevig Mission/1/18 virus bound only weakly
nucleolin and fibrillarin, while the wt NS1 protein of the
H7N3 subtype mallard/Neatherlands/12/00 virus showed
a weak binding to fibrillarin but not to the other tested
nucleolar proteins (Figure 4). The GST-NS1/Udorn/72
(amino acids 1–73) fusion protein clearly pulled-down
nucleolin and fibrillarin showing the role of the N-
terminus of the NS1 protein of the H3N2 subtype A/
Udorn/72 influenza virus in these interactions. The
interactions were totally abolished by R38A and K41A
substitution mutations (Figure 4) and therefore the
interactions are most likely dependent on NLS1 of the
NS1 protein. The GST-NS1 A/Udorn/72 (amino acids
203–237) fusion protein bound nucleolin and fibrillarin
as efficiently as the wt NS1 protein (Figure 4) show-
ing the crucial role played by the C-terminus of the
NS1 protein in these direct interactions. This binding
was totally abolished by K219A,R220A+R231A,R232A
Figure 2 The C-terminal end of the NS1 protein in H3N2 type influenza A viruses encode for a functional NoLS. (A) The N- and
C-terminal fragments of the NS1 genes, encoding for amino acids 1–73 and 157–237 in A/Udorn/72, amino acids 1–73 and 157–230 in A/WSN/33
and amino acids 203–230 in A/Brevig Mission/1/18, were inserted into the GFP expression vector pCMX-SAH/Y145F to express GFP-NS1 fusion
proteins. Mutations in the C-terminal NLS2/NoLS of A/Udorn/72 virus NS1 protein were performed as described in Materials and Methods. Red
boxes indicate the positions of N-terminal NLS1 and C-terminal NLS2/NoLS in NS1 protein. (B) HuH7 cells were transiently transfected with GFP,
GFP-NS1 fusion and GFP-NS1 fusion mutant (K219A,R220A+ R231A,R232A) A/Udorn/72 gene constructs, as indicated in the figure, for 48 h.
The intensity of nucleolar localization was scored by immunofluorescence microscopy as no nucleolar staining (−) or weak (+), moderate (++)
or strong (+++) nucleolar staining. Critical basic amino acids involved in nuclear/nucleolar targeting are marked in boldface and underlined.
Mutated amino acids (K219A,R220A+ R231A,R232A) are marked in red. (C) HuH7 cells were transiently transfected with GFP and the GFP-deletion
gene constructs of NS1 A/WSN/33 and NS1 A/Brevig Mission/1/18 for 48 h as indicated in the figure. Critical and mutated amino acids are
marked as above. Bars, 5 μm.
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tified NLS2/NoLS of the Udorn virus NS1 protein [37].
We can therefore conclude that the NLS2/NoLS is
implicated in direct interactions between the NS1 pro-
tein with nucleolin and fibrillarin.The NS1 protein colocalized with nucleolin and to a
minor extent with B23 and fibrillarin in influenza A/
Udorn/72 virus-infected A549 cells
Next, we analyzed the colocalization of H3N2 subtype
influenza A virus NS1 protein with nucleolin, B23 and
Figure 3 The C-terminal NoLS of the NS1 protein in H3N2 subtype influenza A viruses binds nucleolar nucleolin, B23 and fibrillarin in a
GST-NS1 pull-down experiment. (A) N- and C-terminal fragments of the NS1 gene encoding for amino acids 1–73 and 203–237 in A/Udorn/72
and wt genes, encoding for amino acids 1–237 in A/Udorn/72 and amino acids 1–230 in A/Brevig Mission/1/18 and in A/Mallard/Netherlands/12/
00, were inserted into the GST expression vector pGEX 2 T(+) to express GST-NS1 fusion proteins. Mutations were created into the N-terminal
NLS1 and C-terminal NLS2/NoLS in the A/Udorn/72 virus NS1 protein are as indicated in the figure. (B) The cell extracts of cultured A549 cells
were prepared, and proteins in cell extracts were allowed to bind to E. coli-expressed and Sepharose-immobilized GST, GST-NS1 A/Udorn/72 wt,
GST-NS1 A/Udorn/72(1–73), GST-NS1 A/Udorn/72(1–73)R38A, GST-NS1 A/Udorn/72(1–73)K41A, GST-NS1 A/Udorn/72(203–237), GST-NS1 A/Udorn/
72(203–237)K219A,R220A+ R231A,R232A, GST-NS1 A/Brevig mission/1/18 wt and GST-NS1 mallard/Netherlands/12/00 wt at +4 °C for 1 h.
Sepharose-bound proteins were dissolved in Laemmli sample buffer and separated on 8 % SDS-PAGE. Western blots were stained with
anti-nucleolin, -B23 and -fibrillarin immunoglobulins. As a control, A549 cell extract, containing 10 μg of proteins, was stained in lane C.
M indicates the Sepharose matrix-bound proteins. A similar gel was also stained with Coomassie Brilliant Blue to visualize the amount of
Sepharose-immobilized GST and GST-NS1 fusion proteins.
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legend of Figure 5. The strongest colocalization was
observed between NS1 and nucleolin as evidenced by
the merge of green and red signals visible in yellow in
nucleoplasm and nucleolus. On the contrary, the coloca-
lization of the NS1 protein with fibrillarin and B23 was
mainly observed in the nucleolus (yellow in the merge
images). The next step was the quantification of the rela-
tive distribution of both viral and nucleolar proteins
in the nuclei. The signals were measured using ImageJ
software in 3 groups of 30 cells, in which GFP-NS1 isexpressed and either B23, or fibrillarin or nucleolin was
detected by antibodies. The quantification was also per-
formed on 30 control (CTR) cells not expressing NS1
for each nucleolar proteins. The fluorescence intensity
was measured in the nucleoplasm and nucleoli of each
cell (green and red fluorescence for cells expressing NS1
and red fluorescence for control cells) and was normal-
ized to the mean nuclear fluorescence value to compare
the concentration of B23, nucleolin and fibrillarin
respectively very abundant, abundant and less abundant
nucleolar proteins and the distribution of NS1 in each
Figure 4 The C-terminal NoLS of the NS1 protein in the H3N2 subtype influenza A viruses binds in vitro-translated nucleolar nucleolin
and fibrillarin in a GST pull-down experiment. [35S]-labeled and in vitro-translated nucleolin, B23, fibrillarin and, as a control, lamin A/C were
allowed to bind to E. coli-expressed and Sepharose-immobilized GST, GST-NS1 A/Udorn/72 wt, GST-NS1 A/Udorn/72(1–73), GST-NS1 A/Udorn/72
(1–73)R38A, GST-NS1 A/Udorn/72(1–73)K41A, GST-NS1 A/Udorn/72(203–237), GST-NS1 A/Udorn/72 (203–237)K219A,R220A+ R231A,R232A, GST-
NS1 A/Brevig mission/1/18 wt and GST-NS1 A/mallard/Netherlands/12/00 wt at +4 °C for 1 h. Sepharose-bound proteins were dissolved in
Laemmli sample buffer, separated on 8 % SDS-PAGE and autoradiographed. Input (lane C) was 1:10 of the amount of [35S]-labeled protein that
was used in the binding experiment. M indicates the Sepharose matrix-bound proteins. A similar gel was also stained with Coomassie Blue to
visualize the amount of Sepharose-immobilized GST and GST-NS1 fusion proteins.
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distribution of NS1 is quite similar in the NS1-B23,
NS1-fibrillarin, or NS1-nucleolin cells (Figure 5B) indi-
cating that the expression of the NS1 protein is compar-
able in each group. The relative concentration of B23 in
nucleoli in the presence of NS1 is high compared to the
nucleoplasm but only half of that of the control cells
(Figure 5B) suggesting a reduced relative concentration
of B23 in nucleoli in the presence of NS1. The relative
concentration of fibrillarin in the presence of NS1 is
higher in nucleoli than in nucleoplasm but its relative
concentration in the nucleoplasm is two-fold higher as
compared to the control cells (Figure 5B). This could be
due to the modification of the nuclear traffic of fibril-
larin. The same relative distribution was observed for
nucleolin and NS1 (Figure 5B) that is in accordance with
our demonstration of the interaction between these pro-
teins (Figures 3 and 4). It is possible that this interaction
modifies the traffic of nucleolin in the cell because the
relative nucleolar amount is higher in the control cells
than in presence of NS1 (Figure 5B).
To analyze the relative re-distribution of the nucleolar
proteins in the presence of NS1, the relative intensitiesof nucleolus/nucleoplasm ratios for both NS1 and nucle-
olar proteins was compared in each cell. The ratio for
NS1/B23 is 0.19, for NS1/fibrillarin it is 0.77 and for
NS1/nucleolin it is 1.02 (Table 1). The ratios clearly
demonstrate that the relative distribution of nucleolin
and NS1 are similar in nucleolus and nucleoplasm
in each cells (ratio 1) in contrast to fibrillarin and
B23 (ratios 0.77 and 0.19 respectively), which show rela-
tively higher amounts in the nucleoli than NS1. This
analysis of the relative distribution of NS1 and the nu-
cleolar proteins indicates a differential effect probably
related to their function. It is interesting to note that
fibrillarin is involved at the early stage of rRNA proces-
sing, B23 at late stage and nucleolin at different stages
of rRNA processing.
High expression level of the HIV-1 Rev protein inhibited
the nucleolar targeting of the H3N2 subtype influenza A
virus GFP-NS1 protein fusion (amino acids 203–237)
Previously, it has been shown that HIV-1 Rev protein
targets into the nucleolus [40] and binds to nucleolar
B23 [41]. In order to further characterize NS1 nucleolar
binding structures, we coexpressed the GFP-NS1 A/
Figure 5 NS1 protein of the H3N2 subtype influenza A virus
colocalizes with nucleolin in the nucleolus and nucleoplasm
and with B23 and fibrillarin in the nucleolus in influenza A/
Udorn/72 virus-infected A549 cells. (A) A549 cells were infected
with influenza A/Udorn/72 wt viruses (MOI 5) for eight hours, fixed
with 3 % paraformaldehyde and stained with rabbit or guinea pig
anti-NS1 immunoglobulins, followed by fluorescein isothiocyanate-
labeled goat anti-rabbit or anti-guinea pig immunoglobulins. To
detect protein co-localization, cells were double-stained with mouse
anti-nucleolin and anti-B23 or rabbit anti-fibrillarin immunoglobulins,
followed by Rhodamine Red-X-labeled goat anti-mouse or anti-
rabbit immunoglobulins, respectively. The colocalization of proteins
was visualized with confocal laser microscopy. Only the nuclei of the
cells are presented. Bar, 5 μm. (B) The relative distribution of both
viral and nucleolar proteins in the nuclei, as illustrated in A, is
presented. The relative intensity of fluorescence in the nucleolus and
nucleoplasm was quantified by ImageJ software (mean of 30 cells in
each case). The quantification was also performed on 30 control
(CTR) cells not expressing NS1 for each nucleolar protein.
Table 1 The relative re-distribution of nucleolar proteins
in the presence of NS1
Ratio Ratio Ratio







The relative intensities of nucleolus/nucleoli ratios for both NS1 and nucleolar
proteins is compared in each cell. Quantification was done by ImageJ software
(mean of 30 cells in each case). NU: nucleolus; NCP: nucleoplasm.
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HIV-1 Rev protein and analyzed their possible nucleolar
colocalization. The procedure is described in the legend
of Figure 6. In this experiment, cells, expressing low,
medium or high amounts of nucleolar HIV-1 Rev pro-
tein, were selected by the relative intensity of fluorescent
light. 30 cells in all three groups were examined. As
shown in Figure 6, the GFP-NS1( 203–237) fusion pro-
tein and HIV-1 Rev protein completely colocalized in
the nucleolus. Interestingly, a high expression level of
HIV-1 Rev protein totally displaced the GFP-NS1 pro-
tein fusion from the nucleoli to the nucleus. The
phenomenon was clearly seen in all cells expressing high
level of HIV-1 Rev protein. This further indicates that
NS1 protein, and specifically its C-terminal NLS2/NoLS
domain, has a strong nucleolar retention signal that is
likely binding to similar nucleolar proteins/structures as
HIV-1 Rev protein does.
Discussion
Many different viruses target the nucleolus to disrupt
host-cell functions and to recruit cellular proteins to aid
in virus replication. As the primary site of the replication
of positive-strand RNA viruses and most negative-strand
RNA viruses is the cytoplasm, the reason for RNA
viruses to target nuclear structures is not immediately
obvious. However, among RNA viruses, influenza virus
is an exception, since all the essential viral replication
events take place in the nucleus.
We have previously shown that the NS1 protein of the
H3N2 subtype influenza A virus contains a C-terminal
NLS2/NoLS that efficiently targets the protein into the
nucleoli in virus-infected cells [37]. Murayama and co-
workers identified the nucleolar protein, nucleolin, as a
novel NS1-binding protein [38]. They also suggested that
the N-terminal part of the NS1 protein was responsible
for this binding, as judged by a GST pull-down assay
with the GST-fused functional domains of NS1. By laser
confocal microscopy, they observed that NS1 colocalized
Figure 6 Chimeric GFP-NS1 A/Udorn/72/(203–237) colocalizes with HIV-1 Rev protein in the nucleolus, and a high expression level of
HIV-1 Rev protein totally displaced the GFP-NS1(203–237) fusion protein from the nucleoli to the nucleus. HuH7 cells were grown on
coverslips for 24 h and then transiently transfected with HIV-1 Rev and chimeric GFP-NS1 A/Udorn/72/(203–237) gene constructs for 48 h. After
fixation, the cells were stained with rabbit anti-HIV-1 Rev and Rhodamine Red-X -labeled goat anti-rabbit immunoglobulins, followed by analysis
with confocal laser microscopy. A high expression level of HIV-1 Rev protein totally displaced the GFP-NS1(203–237) fusion protein from the
nucleoli to the nucleus (bottom panels). Cells, expressing low, medium or high amounts of nucleolar HIV-1 Rev protein, were selected. Only the
nuclei of the cells are presented. Bar, 5 μm.
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that NS1 was interacting with nucleolin during the
infection [38].
In the present study, instead, we show that the NS1
protein of the human H3N2 subtype influenza A virus
can interact, primarily via its C-terminal NoLS, with the
main nucleolar proteins, nucleolin, B23 and fibrillarin
in vitro. Using GFP-NS1 fusion proteins, we observed
that the N-terminal part of both the H3N2 and H1N1
subtype influenza NS1 protein, containing a functional
NLS1, targeted the chimeric proteins into the cell
nucleus but not to the nucleolus (Figure 2B and C).
However, only the C-terminus of the NS1 protein of the
H3N2 subtype A influenza virus, containing a functionalNLS2/NoLS, targeted the chimeric protein into the
cell nucleus and nucleoli (Figure 2B and C). Mutations
in the NLS2/NoLS abolished both the nuclear and
nucleolar targeting (Figure 2B). A chimeric GFP-NS1 A/
Brevig Mission/1/18(203–230) protein was only faintly
targeted into the cell nucleus and nucleolus (Figure 2C).
These results are in agreement with our previous results
showing that all types of influenza A virus NS1 proteins
have an N-terminal NLS1, while H3N2 subtype viruses
also have an additional NLS, a C-terminal NLS2, which
also functions as a NoLS [37].
As mentioned above, Murayama and co-workers
showed that the N-terminal RNA-binding domain of the
NS1 protein was responsible for the binding to nucleolin
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construct and A549 cell extracts, we were also able to
see a weak binding of nucleolin, B23 and fibrillarin to
the N-terminal part of a chimeric NS1 protein (Figure 3).
The binding was abolished by R38A and K41A substitu-
tion mutations to the RNA-binding domain of the NS1
protein (Figure 3B). The same amino acids are also crit-
ical for the importin α-binding and nuclear transloca-
tion of NS1 protein via the nuclear transport machinery
[37]. Instead, the C-terminal part of the NS1 protein in
the chimeric construct GST-NS1/A/Udorn/72(203–237)
bound nucleolin, B23 and fibrillarin as well as the wt
NS1 protein did (Figure 3B). This binding was totally
abolished by K219A,R220A+R231A,R232A substitution
mutations (Figure 3B), indicating the NLS2/NoLS to
be primarily responsible for the binding of NS1 to nucle-
olar proteins.
The signals that govern the nucleolar localization and
retention of different proteins are not well defined. The
motifs involved are usually rich in arginine and lysine
residues, however, there is no obvious consensus
sequence or structure. Proteins that localize in the
nucleolus can also have nuclear import and export
motifs. It is unclear whether nucleolar proteins are spe-
cifically localized, targeted, accumulated or just retained
in the nucleolus and consequently the sequences asso-
ciated with the nucleolar localization have thus been
designated as nucleolar targeting signals and/or nucle-
olar retention signals. In many cases, proteins that
localize in the cytoplasm and in the nucleus and/or nu-
cleoli contain multiple signals that determine their sub-
cellular localization. This highlights the difficulty in
identifying truly functional NoLSs. Moreover, proteins
that localize in the nucleoli must first be imported into
the nucleus and therefore they likely possess both
NLS and NoLS whose sequences may overlap (Reviewed
in [29].
Our previous [37] and present data clearly shows that
the nucleolar retention of the H3N2 subtype influenza A
virus NS1 protein is mediated primarily by its C-
terminal NLS2/NoLS. However, the N-terminal NLS1
may also mediate weak nuclear retention of NS1 protein,
since the H1N1pdm NS1 protein was weakly localized
into the nucleoli, even if it lacked the C-terminal NLS2/
NoLS due to a stop codon at position 220 (Figure 1).
There may also be viral species-specific differences, since
the 230-amino-acid-long NS1 of the avian A/mallard/
Netherlands/12/00 virus completely failed to target into
the nucleoli (Figure 1).
Nucleoli are compact structures, and thus it was quite
expected that all three major nucleolar proteins co-
precipitated with the H3N2 virus NS1 protein in GST
pull-down experiments. However, in vitro-translated
nucleolar proteins showed that nucleolin and fibrillarinspecifically bound to the C-terminal part of the NS1
protein in a manner similar to that seen with A549 cell
extracts (compare Figures 3 and 4). Instead, in vitro-
translated B23 did not bind to the NS1 protein suggest-
ing that this protein has no intrinsic binding ability to
NS1. However, it coprecipitated with other nucleolar
proteins in GST pull-down experiments (Figure 4). It is
also possible that in vitro-translated B23 is misfolded or
requires additional posttranslational modifications, such
as phosphorylation for the NS1 interaction to take place.
Laser confocal microscopy showed a clear colocaliza-
tion of NS1 with nucleolin, B23 and fibrillarin, indicating
that NS1 was interacting with these proteins during the
virus infection (Figure 5A). The HIV-1 Rev protein has
previously been shown to localize into the nucleolus
(reviewed in [42]). Like many viral proteins that target
into the nucleolus, Rev has also been shown to contain a
functional NoLS [43]. In the nucleolus, HIV-1 Rev pro-
tein binds to nucleolar B23 [41] and localizes to the
combined regions of the dense fibrillar component
and the granular component. To further identify the
interaction partners of NS1 in the nucleolus, we ana-
lyzed nucleolar co-localization of the GFP-NS1 A/
Udorn/72/(203–237) and HIV-1 Rev proteins. GFP-NS1
A/Udorn/72/(203–237) and HIV-1 Rev proteins coloca-
lized in the nucleolus, and high expression level of the
HIV-1 Rev protein totally displaced the chimeric GFP-
NS1(203–237) protein from the nucleolus. This may
indicate that these proteins are binding to similar struc-
tures within the nucleolus or that all nucleolar proteins
have a very tight interaction with each others.
Further analysis of the role of the nuclear retention of
the NS1 protein during influenza virus infection is
needed. The fact that viral proteins contain NoLSs is an
indication that viruses have evolved specific nucleolar
functions. There is emerging evidence that the disrup-
tion of the nuclear or nucleolar trafficking by some
positive-stranded RNA virus proteins may have a role in
viral pathogenesis.
Conclusions
The present study shows that the NS1 protein of the
human H3N2 subtype virus interacts in vitro primarily
via its C-terminal NLS2/NoLS and to a minor extent via
its N-terminal NLS1 with the nucleolar proteins, nucleo-
lin and fibrillarin. Using chimeric green fluorescence
protein (GFP)-NS1 fusion constructs, we show that the
nucleolar retention of the NS1 protein is determined by
its C-terminal NLS2/NoLS in vivo. Confocal laser mi-
croscopy analysis shows that the NS1 protein colocalizes
with nucleolin in nucleoplasm and nucleolus and with
B23 and fibrillarin in the nucleolus of influenza A/
Udorn/72 virus-infected A549 cells. Since some viral
proteins contain NoLSs, it is likely that viruses have
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the nucleolar targeting function of NS1 protein plays a
role in the pathogenesis of human influenza A viruses
that, undoubtedly, deserves further studies.
Methods
Cells
Human A549 lung carcinoma cell line (ATCC, CCL 185)
was maintained in a continuous culture in minimum
Eagle’s medium-α (Invitrogen Corp., Carlsbad, CA,
USA) supplemented with 0.6 μg/ml penicillin, 60 μg/ml
streptomycin and 10% fetal calf serum (Integro, BV, Die-
ren, The Netherlands). Human hepatocellular carcinoma
HuH7 [44] cells were maintained in minimum Eagle’s
medium-α with supplements as above.
Generation of reverse genetics A/WSN/33 (A/Brevig
Mission/1/18 segm 8) virus
Reverse genetics in the A/WSN/33 H1N1 background
[45] was performed using a pHH21 vector containing a
wild-type synthetic gene fragment encoding the A/Brevig
Mission/1/18 NS gene [17]. Viruses were propagated
using Madin-Darby canine kidney (MDCK) cells [46].
Viruses and infections
A549 cells, grown on 6-well plates or on glass coverslips
on 24-well plates, were infected with the following
viruses: A/Udorn/72 (H3N2), A/WSN/33 (H1N1), A/
WSN/33 (A/Brevig Mission/1/18 segm 8) (H1N1), A/Fin/
554/09 (H1N1pdm09) and A/mallard/Netherlands/12/
2000 (H7N3). Virus stocks were cultivated in eight-
day-old embryonated chicken eggs and stored at −70 °C.
The hemagglutination titers of the stock viruses ranged
from 64 to 256, and the infectivity of the virus stocks
in A549 cells was 1-4 × 107 pfu/ml. The multiplicity of
infection (MOI) used in the experiments varied from
0.5 to 5 pfu/cell.
Antibodies
In Western blot analysis mouse monoclonal anti-
nucleolin (anti-C23; sc-8031; 1:1000 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), mouse monoclo-
nal anti-B23 (sc-32256; 1:2000 dilution; Santa Cruz Bio-
technology) and rabbit polyclonal anti-fibrillarin (#2639;
1:200 dilution; Cell Signaling Technology, Inc., Beverly,
MA, USA) immunoglobulins were used. Secondary
HRP-conjugated goat anti-mouse and goat anti-rabbit
immunoglobulins (1:2000 dilution; Daco, Glostrup,
Denmark) were used as suggested by the manufacturer.
Guinea pig anti-influenza NS1 [37] and rabbit anti-HIV-1
Rev [47] immunoglobulins were used in confocal laser
microscopy. Also mouse monoclonal anti-nucleolin (anti-
C23; sc-8031; 1:100 dilution; Santa Cruz Biotechnology),
mouse monoclonal anti-B23 (sc-32256; 1:200 dilution;Santa Cruz Biotechnology) and rabbit polyclonal anti-
fibrillarin (#2639; 1:25 dilution; Cell Signaling Tech-
nology, Inc.) immunoglobulins were used. Secondary anti-
bodies used were Rhodamine- Red-X- or FITC-labeled
goat anti-guinea pig, anti-mouse or anti-rabbit immuno-
globulins, respectively (1:100 dilution; Jackson Immuno-
Research Laboratories, Inc., West Grove, PA, USA).
Plasmids and DNA manipulations
Wild type A/Udorn/72 (H3N2 virus) NS1 gene (Gen-
Bank ID: V01102) was expressed in E. coli GST (pGEX-
3X; Amersham Biosciences, Buckinghamshire, U. K.)
and eukaryotic pcDNA3.1(+) (Invitrogen Corp., Carlsbad,
CA, USA) expression vectors. Wild type A/WSN/33
(H1N1 virus) NS1 gene (GenBank ID: M12597) was mod-
ified by PCR to create N- and C-terminal BglII sites for
further cloning into the BamHI site of the pcDNA3.1(+)
expression vector (Invitrogen). To create point mutations
to the A/Udorn/72 and A/WSN/33 NS1 cDNAs, a Quik-
ChangeTM Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA, USA) was used.
Wild type human nucleolin (C23; GenBank ID:
BC002343), B23 (nucleophosmin; GenBank ID: BC050628),
fibrillarin (FBL; GenBank ID: NM_001436.3) and HIV-1
Rev [48] genes were modified by PCR to create N- and
C-terminal BamHI sites for further cloning into the
BamHI site of the pcDNA3.1(+) expression vector (Invi-
trogen). Wild type human laminA/C (GenBank ID:
NG_008692) gene was cloned into the pOTB7 vector
(Invitrogen).
To create green fluorescence protein (GFP)-NS1 fusion
constructs, N-terminal cDNAs for the wild type A/
Udorn/72 (aa 1–73) and A/WSN/33 (aa 1–73) NS1 and
C-terminal cDNAs (aa 157–237 and 157–230), respect-
ively, and C-terminal cDNA for wild type A/Brevig
Mission/1/18 (aa 203–230) genes were modified by
PCR to create N- and C-terminal SalI and NheI sites, re-
spectively, for further cloning into the SalI and NheI
cloning sites of a pCMX-SAH/Y145F expression vector
[49]. Mutations to the GFP-NS1 chimeric gene con-
structs were done using the QuikChangeTM Site-Directed
Mutagenesis Kit (Stratagene). All oligonucleotides used to
modify the genes in the study will be provided upon request.
All DNA manipulations were performed according to
standard protocols, and the newly created gene con-
structs were partially or fully sequenced.
NS1 binding assay, SDS-PAGE and Western blotting
Influenza A virus GST-NS1 fusion proteins were
expressed in E. coli BL21 cells, and GST-fusion proteins
were purified as described [37]. In vitro-translated
nucleolin, B23 and fibrillarin wt proteins (TNT Coupled
Reticulocyte Lysate Systems, Promega, Madison, WI,
USA) were [35S]-labeled (PRO-MIX, Amersham
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immobilized GST or GST-NS1 fusion proteins on ice for
60 min followed by washing. GST-NS1 fusion protein-
bound [35S]-labeled proteins were separated on 12%
SDS-PAGE. The gels were fixed and treated with Amp-
lify reagent (Amersham Biosciences) as specified by the
manufacturer and autoradiographed. GST pull-down
experiments from A549 cell extracts were carried out as
described [50].Transfections, indirect immunofluorescence and confocal
laser microscopy
For indirect immunofluorescence and confocal laser
microscopy HuH7 cells, grown on glass coverslips for
24 h, were transfected with GFP, GFP-NS1 or HIV-1-
pcDNA3.1(+) expression constructs using FuGENE6
transfection reagent (Roche Diagnostics, Indiapolis, IN,
USA) according to the manufacturer’s instructions.
Forty-eight hours after transfection the cells were fixed
with 3% paraformaldehyde at RT for 20 min and pro-
cessed for immunofluorescence microscopy. A549 cells
were infected with influenza A/Udorn/72 wt virus for
5 to 8 hours as indicated in the legends for figures, fixed
with 3% paraformaldehyde at RT for 20 min, permeabi-
lized with 0.1% Triton X-100 for 5 min and processed
for immunofluorescence microscopy. The cells, positive
for transiently transfected GFP and GFP-NS1 or viral
NS1 proteins, were visualized and photographed on a
Leica TCS NT confocal microscope.
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